By increasing feelings of fullness, slowing digestion, and reducing cravings, GLP-1 therapies help individuals consume fewer calories and achieve sustainable weight loss
Factors such as a high prevalence of diabetes, increasing obesity rates, and a well-established healthcare infrastructure drive the demand for advanced diabetes treatments in this region
Metabolic Benefits Beyond the Scale Weight reduction represents only one dimension of GLP-1 therapy outcomes
Those in the semaglutide treatment group experienced about 11% greater weight loss than the placebo group, reduced inflammation, and improved physical limitations
The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health
Seek immediate medical attention if you are experiencing any extreme symptoms of constipation